Severe Mental Illness: On The Frontier Of Translational Neuroscience
Save the date for the next Stanley Symposium!
September 19-20, 2023
This two-day virtual symposium, chaired by Dr. Steve Hyman, director of the Stanley Center for Psychiatric Research at Broad Institute, Dr. Guoping Feng of McGovern Institute at MIT and director of the Neurobiology and Model Systems group of the Stanley Center, and Dr. Benjamin Neale of Massachusetts General Hospital and director of Genetics at the Stanley Center, brought together scientists working on the frontiers of genetics, neurobiology, computational psychiatry, and therapeutic development for schizophrenia, bipolar disorder, autism spectrum disorder, and related neuropsychiatric disorders.
The central theme in 2021 addressed the challenges of turning biological insights from the developing brain into translational hypotheses that could help patients. Our speakers presented progress in analytic approaches, technologies, and model systems that will help translate results from large-scale genetic studies into new understandings of pathophysiology, biomarker development, and much-needed new treatments.
The illnesses highlighted in this symposium cause lifelong disability to millions of persons — combined, more than 3 percent of the global population is affected by these severe disorders. Graduate students and postdoctoral associates were especially welcomed to this symposium in order to build this interdisciplinary field and address the unmet medical needs of patients and their families at a time of great opportunity and urgency.
All sessions were held virtually, recordings of the talks are available here.